Company
Headquarters: Saint-Sulpice, Switzerland
Employees: 415
CEO: Dr. Jurgi Camblong M.B.A., Ph.D.
Company | Market Cap (USD) |
---|---|
![]() |
$25.12 B |
![]() |
$17.56 B |
![]() |
$9.03 B |
![]() |
$8.38 B |
![]() |
$6.37 B |
Company | Market Cap (USD) |
---|---|
![]() |
$495.37 B |
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$304.61 B |
![]() |
$287.63 B |
SOPHiA GENETICS SA operates as a healthcare technology company. The company creates SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma institutions worldwide. The company was incorporated in 2011 and is based in Saint-Sulpice, Switzerland.
SOPHiA GENETICS SA has the following listings and related stock indices.
Stock: NASDAQ: SOPH